AI assistant
biote Corp. — Director's Dealing 2022
May 31, 2022
33946_dirs_2022-05-31_2e07b62f-e29d-4ad0-a62d-275a6b707c69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: biote Corp. (BTMD)
CIK: 0001819253
Period of Report: 2022-05-26
Reporting Person: Conlon Mary Elizabeth (General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-05-26 | Phantom Stock | $ | A | 157500 | Acquired | 2023-07-01 | Class A Common Stock (157500) | Direct |
Footnotes
F1: Each share of phantom stock is the economic equivalent of one share of Issuer Class A Common Stock.
F2: Received pursuant to the Business Combination Agreement between Haymaker Acquisition Corp. III, a Delaware corporation, Haymaker
Sponsor III LLC, a Delaware limited liability company, BioTE Holdings, LLC, a Nevada limited liability company ("Biote"), BioTE Management,
LLC, a Nevada limited liability company, Dr. Gary Donovitz, in his individual capacity and Teresa S. Weber, in her capacity as the members'
representative.
F3: The phantom stock shall vest on 1/4th on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023.